TY  - JOUR
AU  - Muñoz-Galván, Sandra
AU  - Rivero, Maria
AU  - Peinado-Serrano, Javier
AU  - Martinez-Pérez, Julia
AU  - Fernández-Fernández, M C
AU  - Ortiz, María José
AU  - García-Heredia, José M
AU  - Carnero, Amancio
PY  - 2020
DO  - 10.3390/cells9051071
UR  - http://hdl.handle.net/10668/15454
T2  - Cells
AB  - Colorectal cancer (CRC) is the third most common cancer worldwide. The standard treatment in locally advanced rectal cancer is preoperative radiation alone or in combination with chemotherapy, followed by adjuvant chemotherapy. Rectal cancer is highly...
LA  - en
KW  - PAI-1/Serpin E-1
KW  - Pim kinases
KW  - chemoresistance
KW  - rectal cancer
KW  - therapy
KW  - Adult
KW  - Aged
KW  - Apoptosis
KW  - Biomarkers, Pharmacological
KW  - Biomarkers, Tumor
KW  - Biphenyl Compounds
KW  - Cell Line, Tumor
KW  - Cell Proliferation
KW  - Cell Survival
KW  - Colorectal Neoplasms
KW  - Female
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Recurrence, Local
KW  - Plasminogen Activator Inhibitor 1
KW  - Prognosis
KW  - Protein Kinase Inhibitors
KW  - Protein Serine-Threonine Kinases
KW  - Rectal Neoplasms
KW  - Thiazolidines
TI  - PAI1 is a Marker of Bad Prognosis in Rectal Cancer but Predicts a Better Response to Treatment with PIM Inhibitor AZD1208.
TY  - research article
VL  - 9
ER  -